Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price
₹833.80
Market cap
₹16,389 Cr
Revenue (annual)
₹7,345 Cr
Net profit (annual)
₹674.8 Cr
P/E (TTM)
23.6×Sector 47.3×
Promoter holding
69.87%+0.13% QoQ
FII holding
4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:35 IST BSE
Other Announcement

Alembic Pharmaceuticals Other Announcement

Alembic Pharmaceuticals requested physical shareholders to update KYC and nomination details with MUFG Intime India. Compliance ensures timely dividend credits and prevents withholding per SEBI regulations.

14:30 IST BSE
Other Announcement

Alembic Pharmaceuticals Other Announcement

Alembic Pharmaceuticals submitted its Annual Secretarial Compliance Report for the year ended March 2026. The auditor confirmed full regulatory compliance with no deviations or fines reported.

14:38 IST BSE
Other Announcement

Alembic Pharmaceuticals Other Announcement

Alembic Pharmaceuticals Ltd submitted an annual compliance certificate from a Chartered Accountant for the CRA Family Trust. The certificate confirms compliance with the SEBI Exemption Order dated September 30, 2020, for the financial year ended March 31, 2026.